Filing metadata

Accession number
0001567619-23-000069
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jan 03, 2023
Reporting period
Dec 29, 2022
Description
Insider transaction

Explore SEC Filings Hub